The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.42

Today's change0.00 0.00%
Updated May 4 4:01 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.42

Today's change0.00 0.00%
Updated May 4 4:01 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc closed at (U.S.)$3.42.

Over the last five days, shares have lost 19.91% and are down 44.66% for the last year to date. This security has underperformed the S&P 500 by 58.18% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $3.42
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-44.66%
  • Volume0
  • Average volume (10-day)33,529
  • Average volume (1-month)36,320
  • Average volume (3-month)54,070
  • 52-week range(U.S.) $2.87 to (U.S.) $9.09
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.47
Updated May 4 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,895.55%

BioAmber Inc has a net profit margin of -1,895.55%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.55%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1000
Total other revenue--------
Total revenue1000
Gross profit0000
Total cost of revenue1010
Total operating expense1010119
Selling / general / administrative4344
Research & development5655
Depreciation / amortization1000
Interest expense (income), net operating--------
Unusual expense (income)001--
Other operating expenses, total--------
Operating income-9-10-11-8
Interest income (expense), net non-operating-2-1-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-8-15-9
Income after tax-9-8-15-9
Income tax, total0000
Net income-8-7-14-8
Total adjustments to net income--------
Net income before extra. items-8-7-14-8
Minority interest1111
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8-7-14-8
Inc. avail. to common incl. extra. items-8-7-14-8
Diluted net income-8-7-14-8
Dilution adjustment--------
Diluted weighted average shares26262422
Diluted EPS excluding extraordinary itemsvalue per share-0.30-0.27-0.58-0.38
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.30-0.27-0.55-0.38